Clinical

An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years

By Patrick Hardigan, BS, MS, PhD, Nova Southeastern University, Director of Clinical Research Background Fear of pain is one reason a patient may be apprehensive about a medical procedure. The most common form of pain control, namely local anesthesia, can itself...

Physician Explores Gout Treatment Options

As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the most common form of this type of arthritis in men, according to Dr. Gary Myerson, a founding fellow of the American College of Rheumatology....

The Difference Between Topical and Transdermal Medications

White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract Topical medications are widely used as prescription or over the counter (OTC) treatments for a variety of conditions. Though, their use is common, there exists...

Working In All Disease States and Cost Management Areas to Help Patients Access Medications

Gensco® President and CEO, Carlos Alfaras, recently moderated a Thought Interaction Pod (TIP) session at the ECRM Specialty Pharmacy EPPS on the topic of “Disease States and Cost Management; The Transitioning of Care in the Changing Healthcare Landscape.”...

Advances in Treatment of Painful Wounds

by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management | November 2016 Wound management is one of the most common aspects of podiatric practice. The etiology of the wound may vary from post-surgical, traumatic, or disease...

Gensco’s Astero hydrogel alleviates diabetic foot ulcers

As seen in Chain Drug Review’s Diabetes Care Report.
Approximately 15% of people with diabetes suffer from foot ulcers, and treating them properly can be challenging for the patient. However, failure to do so, with resulting infection, carries the danger of eventual amputation.